TNFRSF11A and plasma cell myeloma: Moreover, the RANKL/RANK/OPG system is disregulated in several tumors, such as breast cancer, malignant bone tumors, multiple myeloma, giant cell tumors of bone, chondroblastoma, neuroblastoma and squamous cell carcinoma [8]–[14].